Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prolonged-release film-coated oral tablet (dose form) |
Is a |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Gastro-resistant and prolonged-release oral tablet |
Is a |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Paliperidone 9 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Paliperidone 6 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Paliperidone 3 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
amoxicillin 775 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 300 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 200 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 348 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
guanfacinhydrokorid 4 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
guanfacinhydrokorid 3 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
guanfacinhydrokorid 1 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Nicotinic acid 250 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
guanfacinhydrokorid 2 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
ropinirol 3 mg, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Potassium chloride 1.5 g prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 375 mikrogram, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 750 mikrogram, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 1,5 milligram, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Trazodone hydrochloride 150 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 4,5 milligram, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 3 milligram, depåtablett |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Nevirapine 400 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
False |
tablett med förlängd frisättning |
Inferred relationship |
Some |
|